Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What is the best binder for ivermectin?Does medicare cover incruse ellipta?How much is emgality out of pocket?Who manufactures metoprolol?When was tagrisso approved?
See the DrugPatentWatch profile for Metoprolol
Metoprolol API Suppliers in India Several Indian pharmaceutical companies are involved in the manufacturing and supply of Metoprolol Active Pharmaceutical Ingredient (API). These suppliers cater to both domestic and international markets, contributing to the global availability of this widely used cardiovascular medication. Who makes Metoprolol API in India? Key manufacturers and suppliers of Metoprolol API in India include companies like Granules India Limited, Sun Pharmaceutical Industries Ltd., and Aarti Drugs Ltd. These companies have established production capabilities for Metoprolol Tartrate and Metoprolol Succinate, the two common salt forms. What is the status of Metoprolol patents? The patent landscape for Metoprolol is complex, with many foundational patents having expired. However, patents can exist for specific formulations, manufacturing processes, or new therapeutic uses. Information regarding the patent status for Metoprolol and its various forms can be found on DrugPatentWatch.com [1]. This resource tracks patent expirations and can help identify potential opportunities for generic competition. How is Metoprolol used? Metoprolol is a beta-blocker prescribed to treat a range of cardiovascular conditions. It is commonly used to manage high blood pressure (hypertension), angina (chest pain), and to improve survival after a heart attack. It is also used to treat or prevent heart rhythm irregularities and to reduce symptoms of hyperthyroidism [2]. What are the different forms of Metoprolol? Metoprolol is available in several forms, primarily Metoprolol Tartrate and Metoprolol Succinate. Metoprolol Tartrate is typically formulated for immediate-release and is taken multiple times a day, whereas Metoprolol Succinate is designed for extended-release, allowing for once-daily dosing [3]. Can generic Metoprolol be manufactured after patent expiry? Once the relevant patents expire and regulatory approvals are obtained, generic manufacturers can produce and market Metoprolol. The availability of Indian API suppliers is crucial for the cost-effective production of generic Metoprolol formulations worldwide. How does India play a role in global API supply? India is a significant global hub for API manufacturing due to its robust chemical and pharmaceutical industry, skilled workforce, and competitive manufacturing costs. Indian API suppliers, including those for Metoprolol, play a vital role in ensuring the affordability and accessibility of essential medicines globally [4]. Sources: [1] https://drugpatentwatch.com/ [2] Metoprolol - Wikipedia. (n.d.). Retrieved from https://en.wikipedia.org/wiki/Metoprolol [3] Metoprolol Succinate vs. Metoprolol Tartrate: What's the difference? (n.d.). Retrieved from https://www.medicalnewstoday.com/articles/metoprolol-succinate-vs-tartrate [4] India's Role in the Global Pharmaceutical Market. (n.d.). Retrieved from https://www.pharmaceutical-technology.com/features/featureindias-role-in-global-pharmaceutical-market/
Other Questions About Metoprolol :